AU6332396A - Platelet-specific chimeric immunoglobulin and methods of use therefor - Google Patents

Platelet-specific chimeric immunoglobulin and methods of use therefor

Info

Publication number
AU6332396A
AU6332396A AU63323/96A AU6332396A AU6332396A AU 6332396 A AU6332396 A AU 6332396A AU 63323/96 A AU63323/96 A AU 63323/96A AU 6332396 A AU6332396 A AU 6332396A AU 6332396 A AU6332396 A AU 6332396A
Authority
AU
Australia
Prior art keywords
platelet
methods
specific chimeric
chimeric immunoglobulin
use therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63323/96A
Inventor
Barry S Coller
David M Knight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Janssen Biotech Inc
Original Assignee
Research Foundation of State University of New York
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York, Centocor Inc filed Critical Research Foundation of State University of New York
Publication of AU6332396A publication Critical patent/AU6332396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU63323/96A 1995-06-07 1996-06-05 Platelet-specific chimeric immunoglobulin and methods of use therefor Abandoned AU6332396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US475526 1983-03-15
US47552695A 1995-06-07 1995-06-07
PCT/US1996/010216 WO1996040250A2 (en) 1995-06-07 1996-06-05 Platelet-specific chimeric immunoglobulin and methods of use therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU58388/99A Division AU5838899A (en) 1995-06-07 1999-11-09 Platelet-specific chimeric immunoglobulin and methods of use therefor

Publications (1)

Publication Number Publication Date
AU6332396A true AU6332396A (en) 1996-12-30

Family

ID=23887963

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63323/96A Abandoned AU6332396A (en) 1995-06-07 1996-06-05 Platelet-specific chimeric immunoglobulin and methods of use therefor

Country Status (7)

Country Link
EP (1) EP0835135A2 (en)
JP (1) JPH11511120A (en)
CN (1) CN1186439A (en)
AU (1) AU6332396A (en)
CA (1) CA2223885A1 (en)
NZ (1) NZ513882A (en)
WO (1) WO1996040250A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590079B2 (en) 1997-01-30 2003-07-08 Ixsys, Incorporated Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
US6596850B1 (en) 1998-01-30 2003-07-22 Ixsys, Incorporated Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
NZ512055A (en) * 1998-11-03 2003-11-28 Centocor Inc Modified antibodies and antibody fragments with increased duration of activity
AUPP783198A0 (en) * 1998-12-21 1999-01-21 Resmed Limited Determination of mask fitting pressure and correct mask fit
WO2000066160A1 (en) * 1999-04-28 2000-11-09 Yamanouchi Pharmaceutical Co., Ltd. Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same
US6531580B1 (en) 1999-06-24 2003-03-11 Ixsys, Inc. Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
WO2005079863A1 (en) * 2004-02-25 2005-09-01 Astellas Pharma Inc. Contrast medium for thrombus formation
EP2789631A1 (en) * 2013-04-10 2014-10-15 Synapse B.V. Compounds and methods for inhibition of binding of ICAM-4 to platelet integrin alphaIIbbeta3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
AU665529B2 (en) * 1991-01-17 1996-01-11 Board Of Regents Of The University Of Washington, The Anti-growth factor antibodies in the treatment of vascular stenosis
NZ527820A (en) * 1993-11-05 2005-04-29 Centocor Inc Platelet-specific chimeric immunoglobulin and methods of use therefor

Also Published As

Publication number Publication date
EP0835135A2 (en) 1998-04-15
NZ513882A (en) 2001-09-28
CN1186439A (en) 1998-07-01
WO1996040250A2 (en) 1996-12-19
JPH11511120A (en) 1999-09-28
WO1996040250A3 (en) 1997-01-23
CA2223885A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU6011096A (en) Chimeric leptin fused to immunoglobulin domain and use
AU1087497A (en) Clamp assembly and method of use
AU1209495A (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
AU4617696A (en) Transformer and method of assembly
AU7435296A (en) Novel expression vectors and methods of use
AU5422696A (en) Nox catalyst and method of using the same
ZA949341B (en) Humanized antibodies and uses thereof
AU1023797A (en) Reduction of hair growth
AU5178196A (en) Reduction of hair growth
AU4653996A (en) Logarithm/inverse-logarithm converter and method of using same
AU4930993A (en) Coupled replication-translation methods and kits for protein synthesis
AU7422496A (en) NM03 antibody materials and methods
AU7621496A (en) Microsensor and use of such microsensor
AU5880996A (en) Container and closure assembly and method of making same
AU6750594A (en) Receptors of interleukin-12 and antibodies
AU4013495A (en) Chemokine-like proteins and methods of use
AU7326796A (en) Stable chicken b-cell line and method of use thereof
AU6332396A (en) Platelet-specific chimeric immunoglobulin and methods of use therefor
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU5667896A (en) Tar-depleted liquid smoke and method of manufacture
AU6282696A (en) Functional surrogates of analytes of interest and methods of obtaining and using same
AU5180296A (en) Container and method of making same
AU3342093A (en) Lens and method of making same
AU6667196A (en) Determination of chromium
AU5647894A (en) Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides